Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds B of A Securities Reinstates Buy on Sylvamo

B of A Securities Reinstates Buy on Sylvamo

B of A Securities analyst George Staphos reinstates Sylvamo (NYSE:SLVM) with a Buy.

byBenzinga Newsdesk

October 13, 2022

1 minute read

B of A Securities analyst George Staphos reinstates Sylvamo (NYSE:SLVM) with a Buy.

Why AppLovin Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

February 15, 8:57 AM

Shares of AppLovin Corporation (NASDAQ: APP) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial

APP

News

KFC’s South Africa Unit to Temporarily Shut Some Outlets Due to Power Cuts

By Charles Gross

December 28, 6:18 AM

-Bloomberg https://www.bloomberg.com/news/articles/2022-12-28/kfc-s-south-africa-unit-to-shut-some-outlets-due-to-power-cuts?sref=y3YMCJ4e

YUM

News

Apple Supplier Foxconn’s February Revenue Slumps As Consumer Electronics Business Slows: What That Means For Tech Giant

By Shanthi Rexaline

March 5, 4:46 PM

Apple, Inc.

AAPL

Schizophrenia Player BioXcel’s Drug Faces Funding Headwinds, Analyst Downgrades Stock

By Vandana Singh

October 5, 2:56 PM

Truist downgraded BioXcel Therapeutics Inc (NASDAQ: BTAI) from Buy to Hold, citing significant near-term funding and

BTAI

B of A Securities Reinstates Buy on Sylvamo

Related Posts

Why AppLovin Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

KFC’s South Africa Unit to Temporarily Shut Some Outlets Due to Power Cuts

Apple Supplier Foxconn’s February Revenue Slumps As Consumer Electronics Business Slows: What That Means For Tech Giant

Schizophrenia Player BioXcel’s Drug Faces Funding Headwinds, Analyst Downgrades Stock